Measuring the Economic Footprint of the Biotechnology Industry in the European Union: 2008–2024
Third-Party20/11/26
EuropaBio will launch the third edition of Measuring the Economic Footprint of the Biotechnology Industry in the European Union: 2008–2024.
The study from the WifOR Institute examines biotechnology’s contribution to the European economy, including economic growth, employment, productivity, trade and R&D, as well as its wider impact across European value chains. This report is cited extensively by the European Commission and has been referenced in all legislative proposals where biotech is included. It will have a dedicated webpage, be distributed across the European Commission, and used to underpin Biotech Act II asks.
What happens on launch day, November 17th
The press distribution is underway now, and EuropaBio will contact you early on 17th with the LinkedIn post and final public version of the report. It will be excellent if you can like, comment and reshare, together with your own activities in biotech innovation and manufacturing. This will be followed by a dedicated communication campaign from EuropaBio.
Join the webinar on November 20th, 11h00 CET
A public launch webinar will take a closer look at the report and Board members will discuss what the latest evidence tells us about the development of Europe’s biotechnology industry and the opportunities ahead.
Board speakers are Ana Maria Bravo (IFF), Hugh Pullen (Novartis), Ricardo Gent (DIB) and Sinead Keogh (IBEC), plus Dennis Ostwald (WifOR Institute).
Would you like to join? Visit the event website to register online.